Search by Drug Name or NDC

    NDC 00135-0539-02 PANADOL 160 mg/5mL Details

    PANADOL 160 mg/5mL

    PANADOL is a ORAL SUSPENSION in the HUMAN OTC DRUG category. It is labeled and distributed by GlaxoSmithKline Consumer Healthcare Holdings (US) LLC. The primary component is ACETAMINOPHEN.

    Product Information

    NDC 00135-0539
    Product ID 0135-0539_be98c798-4afe-4975-9936-b3bca28e2bd7
    Associated GPIs 64200010001840
    GCN Sequence Number n/a
    GCN Sequence Number Description n/a
    HIC3 n/a
    HIC3 Description n/a
    GCN n/a
    HICL Sequence Number n/a
    HICL Sequence Number Description n/a
    Brand/Generic n/a
    Proprietary Name PANADOL
    Proprietary Name Suffix n/a
    Non-Proprietary Name acetaminophen
    Product Type HUMAN OTC DRUG
    Dosage Form SUSPENSION
    Route ORAL
    Active Ingredient Strength 160
    Active Ingredient Units mg/5mL
    Substance Name ACETAMINOPHEN
    Labeler Name GlaxoSmithKline Consumer Healthcare Holdings (US) LLC
    Pharmaceutical Class n/a
    DEA Schedule n/a
    Marketing Category OTC MONOGRAPH NOT FINAL
    Application Number part343
    Listing Certified Through 2024-12-31

    Package

    NDC 00135-0539-02 (00135053902)

    NDC Package Code 0135-0539-02
    Billing NDC 00135053902
    Package 1 BOTTLE in 1 CARTON (0135-0539-02) / 54.7 mL in 1 BOTTLE
    Marketing Start Date 2012-10-15
    NDC Exclude Flag N
    Pricing Information N/A

    Standard Product Labeling (SPL)/Prescribing Information SPL 95801755-db54-4ad7-bec1-52671914f6ca Details

    Revised: 12/2020